DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

1.05
Delayed Data
As of Feb 23
 +0.0809 / +8.35%
Today’s Change
0.78
Today|||52-Week Range
5.20
-3.67%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +1,042.86% increase from the last price of 1.05.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in DelMar Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$0.00
Reporting Date
May 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.14%
 
 
 
 
 
 
Growthannually 37.84%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
Key to the earnings and sales forecast charts.